Department of Biomedical Genetics, The Aab Institute of Biomedical Sciences, University of Rochester Medical Center, 601 Elmwood Avenue, Box 633, Rochester, NY 14642
Received 15 December 2004/ Returned for modification 26 January 2005/ Accepted 4 April 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
We have previously analyzed the changes of gene expression as cells of the developing Drosophila melanogaster eye transit from a pluripotent and mitotically active precursor state to terminally differentiated cell types that comprise the adult eye (10). These studies identified a population of genes that are selectively expressed in the dividing precursor cells located anterior to the morphogenetic furrow of the eye imaginal disc. Genes of this group encode proteins that are typical of a dividing and metabolically active cell, such as replication factors and protein synthesis components. Many of these loci are preceded by a binding site for the DREF (DNA replication-related element factor) protein that had previously been identified as a potential regulator of genes involved in cell cycle and growth regulation. Significantly, no DREF binding sites, or DREs, were identified in the upstream regions of genes that were selectively expressed in postmitotic differentiating cells (10). Consistent with our conclusions, recent microarray experiments in cell culture suggest DREF to be dedicated to the regulation of genes involved in cell proliferation (9).
DREF is an unusual transcription factor in that it combines features of bona fide sequence-selective promoter- and enhancer-binding proteins and of the basal transcription machinery. DREF is a component of a transcription initiation complex containing TRF2 (9). Consistent with the idea that DREF acts like a general transcriptional regulator with functional links to a TFIID-like activity, a computational study, which analyzed core promoters in the Drosophila genome, identified the DRE as one of the most prevalent motifs in Drosophila core promoters (15). The molecular properties of DREF thus set it apart from "classical" cell cycle-regulating transcription factors, such as E2F and Myc, and a better understanding of the functional role of DREF in the control of cell proliferation and tissue growth thus seems important.
DREF appears to be evolutionarily conserved, as recent studies have identified a potential human homolog (17). As in Drosophila, DRE-related sequences were found in the promoter regions of human genes involved in cell proliferation and cell cycle regulation. Interestingly, cell culture studies suggest that DREF regulates gene expression during the G1-to-S cell cycle progression in humans (17).
Due to the lack of loss-of-function alleles, the functional characterization of DREF has until now focused predominantly on promoter analyses of DRE-regulated genes in cell culture, and a limited number of studies have been conducted to investigate the effect of artificially increased DREF function in the organism (8, 16, 20, 25, 26). We and others have shown that ectopic expression of DREF can promote DNA replication in the eye imaginal disc, but overgrowth of the adult tissue was not detected, presumably because superfluous cells were eliminated from the developing tissue by apoptosis (7). DREF overexpression thus has phenotypic consequences that are similar to the effect of overexpression of E2F1 and other cell cycle regulators (2, 14, 18). In this study, we present evidence that DREF is required for the expression of cell cycle-related genes and for the control of cell proliferation during organ development in the fly.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Generation of transgenic flies. To generate the DREFRNAi construct (see schematic in Fig. 1A), a 1.28-kb genomic DNA fragment including exons 2, 3, and 4 was amplified with primers containing EcoRI and NotI restriction sites. For amplification of a 1.15-kb cDNA fragment spanning exons 2, 3, and 4, primers containing Asp718 and NotI restriction sites were used. The two fragments were ligated in tail-to-tail orientation via their respective NotI sites, and the ligation product was cloned as an EcoRI-Asp718 fragment into the pUAST transformation vector. Two independent transgenic lines carrying upstream activation sequence (UAS) DREFRNAi were established by P-element-mediated germ line transformation (21). One line carries the RNA interference (RNAi) construct on the X chromosome and one on the third chromosome. The fly line carrying the construct on the X chromosome generates stronger DREF knockdown phenotypes than the one with the insertion on the third chromosome. Except in the experiment in which measurement of adult wing size was conducted with moderate level of DREFRNAi expression (Fig. 2), the stronger X-linked RNAi line was used throughout this study.
|
|
Area and cell size measurement in adult wings and eyes. Wing size was measured by counting pixels on digital images using Adobe Photoshop. The size of cells in the adult wing was determined in the following way. The number of trichomes in areas of defined size in the posterior compartment of adult wings was counted. Cell size was estimated by calculating the wing area per trichome. Eye size was quantitated by measuring the circumference of eyes of the respective phenotypes using digital images and Adobe Photoshop.
Clonal analysis. Random clones were generated in larval wing discs using the FRT/FLP method (23). Flies homozygous for hsFLP (Act5C>CD2>Gal4 and UAS enhanced green fluorescent protein [EGFP]) were crossed with either flies carrying UAS DREFRNAi or Oregon R. Eggs were collected for 4 h and larvae were heat shocked at 63 ± 2 h after egg deposition for 2 h at 37°C. Wing discs were dissected and fixed at 112 h after egg deposition. GFP-positive clones in more than 30 wing discs in each genotype were analyzed using a Leica TCS SP2 confocal microscope, and the area of each clone was determined using Adobe Photoshop.
Flow cytometry. To express DREFRNAi in an inducible manner, we employed the Gal4/Gal80 TARGET system (13). Flies bearing UAS DREFRNAi were crossed with flies carrying T80Gal4, UAS EGFP; tubGal80TS. Eggs were collected for 3 h and larvae were raised at 22°C until heat shock at 37°C for 2 h for induction. After induction, larvae were kept at 25°C until dissection. To measure cell size in the wing disc using forward scatter, UAS DREFRNAi flies were crossed with flies carrying enGal4 and UAS EGFP. Cell dissociation and sorting from third instar larvae wing disc were performed as described previously (14) for each experiment.
| RESULTS |
|---|
|
|
|---|
We tested the efficiency of spatially restricted DREF knockdown using in situ hybridization with a Dref-specific probe that does not overlap with the double-stranded RNA construct (Fig. 1A). In the third instar larval wing imaginal disc of wild-type animals, Dref mRNA is uniformly distributed (Fig. 1C). However, when DREFRNAi was expressed in the posterior compartment using the engrailed Gal4 (enGal4) driver, Dref mRNA levels were markedly decreased in this region (Fig. 1D).
Overexpression of DREF in the posterior compartment of the wing resulted in developmental defects (Fig. 1E). Similarly, loss of DREF function, brought about by DREFRNAi expression at high levels (from the X-linked transgene), severely disrupted normal wing development (Fig. 1F). These two effects neutralized each other, and the wing developed normally when DREFRNAi was coexpressed with DREF (Fig. 1G). This result indicates that the phenotype elicited by the RNAi construct was caused by a specific decrease of Dref mRNA. Consistent results were observed in the eye, where DREFRNAi could suppress the aberrant eye phenotype elicited by DREF overexpression (Fig. 1H and I).
To test whether DREF is required for normal organ growth, we analyzed the consequences of DREF knockdown in the developing wing and eye. In the fly, the effect of transgenes on tissue growth can be conveniently assessed by overexpressing them under the control of enGal4 in the posterior compartment of the wing. In such a setting, the size of the anterior compartment serves as an internal wild-type control. We analyzed a Drosophila line carrying the moderately expressing DREFRNAi transgene on the third chromosome to assess wing disc growth in a DREF loss-of-function situation. Using this allele, we avoided the massive growth and developmental defects observed in wings in which DREF function was ablated more dramatically (Fig. 1F). Such conditions of limited knockdown of DREF expression did not affect patterning, but growth of the posterior compartment was significantly reduced, indicating that wild-type levels of DREF are critically required for normal tissue growth (Fig. 2A to C). The observed reduction in wing size correlates with a smaller cell size in the posterior compartment, as revealed by a higher density of trichomes in the area of DREFRNAi expression (Fig. 2D). At higher levels of DREFRNAi expression, more severe phenotypes manifested themselves, possibly including patterning defects. This is consistent with recent reports that implicate DREF in mitogen-associated protein kinase-dependent vein differentiation (27). Whether such aberrant patterning phenotypes are a primary consequence of DREF deficiency or an indirect effect of growth defects cannot be judged based on the evidence presently available.
The expression pattern of Dref in the developing Drosophila eye imaginal disc is consistent with its proposed predominant function in cell proliferation. Dref mRNA is expressed at high levels in the dividing and growing cells of the eye imaginal disc, which are located anterior to the morphogenetic furrow (MF) (Fig. 3A). The MF consists of cells that have arrested in G1 phase of the cell cycle in a coordinated fashion. Posterior to the MF, some cells become determined and differentiate into photoreceptors, while others undergo one more cell division and are thus part of the "second mitotic wave" (3). DREF expression is low posterior to the second mitotic wave, suggesting that it is not required for normal photoreceptor differentiation. Consistent with this notion, expression of DREFRNAi in differentiating cells of the eye did not interfere with normal eye development (Fig. 3B and D). However, when expressed in the whole-eye imaginal disc, including areas of active cell proliferation, DREFRNAi induced drastically aberrant phenotypes. These ranged from small, rough eyes to the complete loss of the organ (Fig. 3F). We conclude that DREF function is required for normal growth and cell proliferation in the eye but does not contribute significantly to the patterning and differentiation processes that shape the eye after cell proliferation has ceased.
|
|
|
DREF induces cell cycle-related target genes in vivo.
Next, we examined whether DREF-regulated gene expression might account for the cell cycle effects described above. This possibility is supported by the prevalence of DRE sites in the 5' region of genes involved in cell growth and proliferation (10). To analyze potential DREF-inducible changes in expression of such potential DREF targets, we ubiquitously expressed either wild-type DREF or DREFRNAi in larvae and performed semiquantitative RT-PCR analysis (Fig. 6). Consistent with previous observations (8, 16, 19, 20), overexpression of wild-type DREF increased mRNA levels of genes that are known to promote G1-S transition and that are required for S phase, including cyclin E, cyclin A, dE2F1, myb, the DNA polymerase
gene, and PCNA. The same genes were down-regulated in loss-of-function conditions for DREF. Our studies identified the orc2 gene (origin recognition complex subunit 2) as a novel DREF target. Its 5' promoter region was found to bear three putative DREF binding sites (48 bp before the start codon), and our RT-PCR results showed that overexpression of DREF increased orc2 transcript levels and loss of DREF reduced them in vivo. These results demonstrate that DREF is sufficient and required to induce the expression of genes involved in S-phase progression in vivo and suggest that the absence of the DREF-induced gene expression program is the cause for the reduced size of DREFRNAi-expressing tissues. To test whether DREF would specifically be required for S phase or might also affect other stages of the cell cycle, we measured the RNA levels of cyclin B and string (the Drosophila homolog of cdc25) as representative regulators of the G2-M transition in DREF gain- and loss-of-function conditions. As opposed to the effect on S-phase genes, gain of DREF function did not result in up-regulation of these mitotic genes, indicating that their expression is not controlled by the transcription factor. This is consistent with the absence of recognizable DREF binding motifs in the respective promoter regions. cyclin B and string expression levels were modestly reduced in the DREF knockdown background. This effect is most likely indirect and explained by the smaller fraction of cells that reach the G2-M phase in conditions of reduced DREF activity (Fig. 5B).
|
Growth promotion by DREF gain of function. Our results indicate that DREF directs a gene expression program that should promote cell proliferation in developing imaginal discs and increase organ size. Accordingly, gain-of-function situations for DREF may be expected to result in tissue overgrowth. It has been difficult to directly test this hypothesis, as DREF overexpression resulted in an increase in cell cycle markers in the developing disc that was accompanied by widespread apoptosis (7). The resulting adult organ thus typically did not show overgrowth. We reasoned that higher than wild-type levels of DREF activity might cause problems during replication and result in cell death that is initiated by common cell cycle checkpoints and developmental safeguards.
We wanted to examine whether a DREF-driven growth program would become apparent in conditions of suppressed apoptosis. Thus, we conducted genetic interaction experiments by crossing flies in which DREF was overexpressed in cells of the developing eye imaginal disc with flies carrying a homozygous viable loss-of-function allele of the proapoptotic gene head involution defective, hid(W1) (1, 6). In agreement with our hypothesis, eyes expressing DREF in hid mutant backgrounds grew larger than eyes in control animals (Fig. 7A and B). In addition to increased eye circumference, as quantified in figure Fig. 7F, DREF-overexpressing eyes frequently displayed bulged-out areas of overgrowth (Fig. 7A, arrowhead) when both copies of wild-type hid were eliminated. These data demonstrate that, consistent with its molecular targets and its effects on cells, DREF overexpression is sufficient to promote tissue growth during larval development.
|
| DISCUSSION |
|---|
|
|
|---|
The size of DREF-deficient cells in proliferating imaginal disc tissues is slightly larger than that of wild-type cells, which we interpret as a consequence of delayed S-phase entry. In contrast, the size of cells in the adult wing that has developed in conditions of a partial loss of DREF function brought on by moderate RNAi expression is slightly decreased. This phenotype of postmitotic wing cells may be mediated by effects of DREF on functions other than cell cycle progression. In addition to cell cycle regulators, DREF has been proposed to regulate the expression of proteins involved in anabolic functions (such as ribosomal proteins and tRNA synthetases) (10). In postmitotic cells, defects in the expression of such genes might cause a growth defect that is not apparent in cycling DREF-deficient cells where regulators of G1-S progression appear to be limiting.
Ectopic activation of DREF can drive even differentiating cells into S phase (7). Such a forced entry into the cell cycle may cause the induction of apoptosis. Indeed, when a known mediator of cell death, Hid, is inactivated, DREF-induced apoptosis is suppressed and tissue overgrowth can be observed. Whether the mammalian relative of DREF that has recently been identified has similar functions and might, as such, contribute to malignant overgrowth, for example, in a p53 mutant background, is an intriguing possibility that remains to be examined.
| ACKNOWLEDGMENTS |
|---|
We thank Christine Sommers for expert technical help and generation of transgenic fly lines and Katsuhito Ohno for fly stock carrying UAS DREF. Peter Keng and Tara Calcagni provided assistance in generating and interpreting FACS data.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Asano, M., J. R. Nevins, and R. P. Wharton. 1996. Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. Genes Dev. 10:1422-1432.
3. Baker, N. E. 2001. Cell proliferation, survival, and death in the Drosophila eye. Semin. Cell Dev. Biol. 12:499-507.[CrossRef][Medline]
4. Brand, A. H., and N. Perrimon. 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415.[Abstract]
5. Davidson, I. 2003. The genetics of TBP and TBP-related factors. Trends Biochem. Sci. 28:391-398.[CrossRef][Medline]
6. Grether, M. E., J. M. Abrams, J. Agapite, K. White, and H. Steller. 1995. The head involution defective gene of Drosophila melanogaster functions in programmed cell death. Genes Dev. 9:1694-1708.
7. Hirose, F., N. Ohshima, M. Shiraki, Y. H. Inoue, O. Taguchi, Y. Nishi, A. Matsukage, and M. Yamaguchi. 2001. Ectopic expression of DREF induces DNA synthesis, apoptosis, and unusual morphogenesis in the Drosophila eye imaginal disc: possible interaction with Polycomb and trithorax group proteins. Mol. Cell. Biol. 21:7231-7242.
8. Hirose, F., M. Yamaguchi, H. Handa, Y. Inomata, and A. Matsukage. 1993. Novel 8-base pair sequence (Drosophila DNA replication-related element) and specific binding factor involved in the expression of Drosophila genes for DNA polymerase alpha and proliferating cell nuclear antigen. J. Biol. Chem. 268:2092-2099.
9. Hochheimer, A., S. Zhou, S. Zheng, M. C. Holmes, and R. Tjian. 2002. TRF2 associates with DREF and directs promoter-selective gene expression in Drosophila. Nature 420:439-445.[CrossRef][Medline]
10. Jasper, H., V. Benes, A. Atzberger, S. Sauer, W. Ansorge, and D. Bohmann. 2002. A genomic switch at the transition from cell proliferation to terminal differentiation in the Drosophila eye. Dev. Cell 3:511-521.[CrossRef][Medline]
11. Kalidas, S., and D. P. Smith. 2002. Novel genomic cDNA hybrids produce effective RNA interference in adult Drosophila. Neuron 33:177-184.[CrossRef][Medline]
12. Kimmins, S., N. Kotaja, I. Davidson, and P. Sassone-Corsi. 2004. Testis-specific transcription mechanisms promoting male germ-cell differentiation. Reproduction 128:5-12.
13. McGuire, S. E., P. T. Le, A. J. Osborn, K. Matsumoto, and R. L. Davis. 2003. Spatiotemporal rescue of memory dysfunction in Drosophila. Science 302:1765-1768.
14. Neufeld, T. P., A. F. de la Cruz, L. A. Johnston, and B. A. Edgar. 1998. Coordination of growth and cell division in the Drosophila wing. Cell 93:1183-1193.[CrossRef][Medline]
15. Ohler, U., G. C. Liao, H. Niemann, and G. M. Rubin. 2002. Computational analysis of core promoters in the Drosophila genome. Genome Biol. 3(12):research00871-0087.12. [Online.]
16. Ohno, K., F. Hirose, K. Sakaguchi, Y. Nishida, and A. Matsukage. 1996. Transcriptional regulation of the Drosophila CycA gene by the DNA replication-related element (DRE) and DRE binding factor (DREF). Nucleic Acids Res. 24:3942-3946.
17. Ohshima, N., M. Takahashi, and F. Hirose. 2003. Identification of a human homologue of the DREF transcription factor with a potential role in regulation of the histone H1 gene. J. Biol. Chem. 278:22928-22938.
18. Sakamuro, D., V. Eviner, K. J. Elliott, L. Showe, E. White, and G. C. Prendergast. 1995. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11:2411-2418.[Medline]
19. Sawado, T., F. Hirose, Y. Takahashi, T. Sasaki, T. Shinomiya, K. Sakaguchi, A. Matsukage, and M. Yamaguchi. 1998. The DNA replication-related element (DRE)/DRE-binding factor system is a transcriptional regulator of the Drosophila E2F gene. J. Biol. Chem. 273:26042-26051.
20. Sharkov, N. V., G. Ramsay, and A. L. Katzen. 2002. The DNA replication-related element-binding factor (DREF) is a transcriptional regulator of the Drosophila myb gene. Gene 297:209-219.[CrossRef][Medline]
21. Spradling, A. C., and G. M. Rubin. 1982. Transposition of cloned P-elements into Drosophila germline chromosomes. Science 218:341-347.
22. Stragier, P., and R. Losick. 1996. Molecular genetics of sporulation in Bacillus subtilis. Annu. Rev. Genet. 30:297-341.[CrossRef][Medline]
23. Struhl, G., and K. Basler. 1993. Organizing activity of wingless protein in Drosophila. Cell 72:527-540.[CrossRef][Medline]
24. Tautz, D., and C. Pfeifle. 1989. A non-radioactive in situ hybridization method for the localization of specific RNAs in Drosophila embryos reveals translational control of the segmentation gene hunchback. Chromosoma 98:81-85.[CrossRef][Medline]
25. Yamaguchi, M., Y. Hayashi, Y. Nishimoto, F. Hirose, and A. Matsukage. 1995. A nucleotide sequence essential for the function of DRE, a common promoter element for Drosophila DNA replication-related genes. J. Biol. Chem. 270:15808-15814.
26. Yoshida, H., Y. H. Inoue, F. Hirose, K. Sakaguchi, A. Matsukage, and M. Yamaguchi. 2001. Over-expression of DREF in the Drosophila wing imaginal disc induces apoptosis and a notching wing phenotype. Genes Cells 6:877-886.[Abstract]
27. Yoshida, H., E. Kwon, F. Hirose, K. Otsuki, M. Yamada, and M. Yamaguchi. 2004. DREF is required for EGFR signalling during Drosophila wing vein development. Genes Cells 9:935-944.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|